Expanding Our Knowledge of Menstrual Irregularities Reported by Females With Tuberous Sclerosis Complex

Overview

Journal Front Reprod Health

Date 2022 Oct 28

PMID 36303615

Authors

Kate Mowrey

Hope Northrup

Syed Shahrukh Hashmi

David Rodriguez-Buritica

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of our study is to expand the knowledge regarding intrinsic reproductive dysfunction in females with TSC and to explore the impact of mTOR inhibitors (mTORi) on menstrual irregularity in the Tuberous Sclerosis Complex (TSC) community.

Methods: An electronic survey composed of author-designed questions set out to evaluate reproductive history, presence of menstrual irregularities, mTORi use, as well as maternal reproductive history among females with TSC.

Results: Of the 68 responses from females with TSC regarding age of menarche, the average age was 12.3 years. 56.5% ( = 48) of respondents reported irregular menstrual cycles and noted a total of 102 menstrual irregularities. There was a cohort of 35 women with a reported history of mTORi use. Of these women, 68.6% ( = 24) reported irregular menstrual cycles after taking mTORi. In comparison, among the females with no history of mTORi use ( = 50) only 48% reported irregular menstrual cycles ( = 24).

Conclusions: Our data expands the knowledge regarding intrinsic menstrual dysregulation present in women with TSC, demonstrates a rate of menstrual irregularities among females taking mTORi, and identifies a tendency toward early menarche that may be a previously unrecognized feature of TSC.

References

Morris D, Jones M, Schoemaker M, Ashworth A, Swerdlow A . Familial concordance for age at menarche: analyses from the Breakthrough Generations Study. Paediatr Perinat Epidemiol. 2011; 25(3):306-11. DOI: 10.1111/j.1365-3016.2010.01183.x. View

Adhikari D, Flohr G, Gorre N, Shen Y, Yang H, Lundin E . Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles. Mol Hum Reprod. 2009; 15(12):765-70. DOI: 10.1093/molehr/gap092. View

Wu T, Mendola P, Buck G . Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics. 2002; 110(4):752-7. DOI: 10.1542/peds.110.4.752. View

Northrup H, Krueger D . Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013; 49(4):243-54. PMC: 4080684. DOI: 10.1016/j.pediatrneurol.2013.08.001. View

Harris T, Lawrence Jr J . TOR signaling. Sci STKE. 2003; 2003(212):re15. DOI: 10.1126/stke.2122003re15. View

Li Y, Corradetti M, Inoki K, Guan K . TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem Sci. 2004; 29(1):32-8. DOI: 10.1016/j.tibs.2003.11.007. View

Castro A, Rebhun J, Clark G, Quilliam L . Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem. 2003; 278(35):32493-6. DOI: 10.1074/jbc.C300226200. View

Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L . Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33(9):1602-1618. PMC: 6112576. DOI: 10.1093/humrep/dey256. View

Au K, Williams A, Roach E, Batchelor L, Sparagana S, Delgado M . Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med. 2007; 9(2):88-100. DOI: 10.1097/gim.0b013e31803068c7. View

10.

Au K, Williams A, Gambello M, Northrup H . Molecular genetic basis of tuberous sclerosis complex: from bench to bedside. J Child Neurol. 2004; 19(9):699-709. DOI: 10.1177/08830738040190091101. View

11.

Braun M, Young J, Reiner C, Poster D, Krauer F, Kistler A . Low-dose oral sirolimus and the risk of menstrual-cycle disturbances and ovarian cysts: analysis of the randomized controlled SUISSE ADPKD trial. PLoS One. 2012; 7(10):e45868. PMC: 3468602. DOI: 10.1371/journal.pone.0045868. View

12.

McKnight K, Wellons M, Sites C, Roth D, Szychowski J, Halanych J . Racial and regional differences in age at menopause in the United States: findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Obstet Gynecol. 2011; 205(4):353.e1-8. PMC: 3202084. DOI: 10.1016/j.ajog.2011.05.014. View

13.

Toffol E, Koponen P, Luoto R, Partonen T . Pubertal timing, menstrual irregularity, and mental health: results of a population-based study. Arch Womens Ment Health. 2013; 17(2):127-35. DOI: 10.1007/s00737-013-0399-y. View

14.

Sparagana S, Franz D, Krueger D, Bissler J, Berkowitz N, Burock K . Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex. PLoS One. 2017; 12(10):e0186235. PMC: 5638404. DOI: 10.1371/journal.pone.0186235. View

15.

Gabitzsch E, Hashmi S, Koenig M, Raia M, Whittemore V, Northrup H . Self-reported reproductive health in women with tuberous sclerosis complex. Genet Med. 2013; 15(12):966-71. DOI: 10.1038/gim.2013.60. View

16.

Adhikari D, Liu K . mTOR signaling in the control of activation of primordial follicles. Cell Cycle. 2010; 9(9):1673-4. DOI: 10.4161/cc.9.9.11626. View

17.

Langton C, Whitcomb B, Purdue-Smithe A, Sievert L, Hankinson S, Manson J . Association of oral contraceptives and tubal ligation with risk of early natural menopause. Hum Reprod. 2021; 36(7):1989-1998. PMC: 8487650. DOI: 10.1093/humrep/deab054. View

18.

Chumlea W, Schubert C, Roche A, Kulin H, Lee P, Himes J . Age at menarche and racial comparisons in US girls. Pediatrics. 2003; 111(1):110-3. DOI: 10.1542/peds.111.1.110. View

19.

Rosenfield R . Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013; 98(9):3572-83. PMC: 3763969. DOI: 10.1210/jc.2013-1770. View

20.

Cabrera S, Bright G, Frane J, Blethen S, Lee P . Age of thelarche and menarche in contemporary US females: a cross-sectional analysis. J Pediatr Endocrinol Metab. 2013; 27(1-2):47-51. PMC: 4137967. DOI: 10.1515/jpem-2013-0286. View